CERo Therapeutics Holdings, Inc. Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CEROW and buy or sell other stocks, ETFs, and their options commission-free!

About CEROW

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. 

CEO
Christopher B. Ehrlich, MBA
CEOChristopher B. Ehrlich, MBA
Employees
—
Employees—
Headquarters
Oakland, California
HeadquartersOakland, California
Founded
Founded
Employees
—
Employees—

CEROW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
17.61K
Average volume17.61K
High today
$0.0159
High today$0.0159
Low today
$0.0159
Low today$0.0159
Open price
$0.0159
Open price$0.0159
Volume
12.13K
Volume12.13K
52 Week high
$0.09
52 Week high$0.09
52 Week low
$0.003
52 Week low$0.003
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.